Valuation: InfuSystem Holdings, Inc.

Market Cap 244M 211M 200M 181M 340M 23.4B 342M 2.38B 918M 11.87B 916M 896M 37.85B P/E 2026 *
28.7x
P/E 2027 * 21.6x
Enterprise Value 244M 211M 200M 181M 340M 23.4B 342M 2.38B 918M 11.87B 916M 896M 37.85B EV / Sales 2026 *
1.68x
EV / Sales 2027 * 1.58x
Free-Float
92.76%
Yield 2026 *
-
Yield 2027 * -
1 day-0.65%
1 week+2.19%
1 month-0.08%
3 months+38.07%
6 months+26.96%
Current year+35.45%
1 week 11.8
Extreme 11.7999
12.45
1 month 11.79
Extreme 11.79
12.5
Current year 7.29
Extreme 7.29
12.97
1 year 7.29
Extreme 7.29
12.97
3 years 4.61
Extreme 4.61
12.97
5 years 4.61
Extreme 4.61
19.14
10 years 1.2
Extreme 1.2
23.26
Manager TitleAgeSince
Chief Executive Officer 49 2025-05-18
Director of Finance/CFO 55 2020-03-11
Chief Tech/Sci/R&D Officer 47 -
Director TitleAgeSince
Chairman 60 2018-12-18
Director/Board Member 64 2019-05-14
Director/Board Member 49 2021-03-17
Date Insider Type Main position Quantity % Market Cap. Importance
9/10/26
BlueLine Partners LLC
OthersCompany -20,000 0.1004%
9/10/26 Other

Director

0 0%
5/18/26 Exercice

Chief Executive Officer

21,379 0.1058%
Change 5-day change 1-year change 3-year change Capi.($)
-0.65%+2.19%+19.59%+15.28% 244M
-0.64%-3.47%-22.44%+0.12% 178B
+0.27%+1.72%+0.59%+14.93% 120B
-1.18%-0.83%+10.50%+80.60% 62.25B
-0.45%-7.52%+5.36%+36.49% 48.54B
+1.83%+3.66%-0.04%-29.60% 49.82B
+2.88%+2.77%+14.94%-9.84% 31.95B
-1.03%-7.09% - - 28.59B
+3.50%+8.61%+42.45%-6.94% 25B
-0.88%-5.52%-13.43%+3.39% 21.59B
Average +0.36%-3.21%+6.39%+11.60% 56.64B
Weighted average by Cap. +0.07%-3.32%-3.29%+12.49%

Financials

2026 *2027 *
Net sales 145M 126M 119M 108M 202M 13.92B 204M 1.42B 546M 7.06B 545M 533M 22.52B 154M 133M 126M 114M 214M 14.78B 216M 1.51B 580M 7.5B 579M 566M 23.9B
Net income 9.68M 8.39M 7.93M 7.18M 13.48M 929M 13.58M 94.64M 36.41M 471M 36.37M 35.56M 1.5B 11.82M 10.24M 9.68M 8.77M 16.45M 1.13B 16.57M 116M 44.45M 575M 44.4M 43.42M 1.83B
Net Debt - -
Logo InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. Its segments include Patient Services and Device Solutions. Its core service within its Patient Services segment is its Oncology Business. Patient Services supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its Device Solutions segment’s core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment, sell treatment-related consumables, and provide biomedical recertification, maintenance and repair services for oncology practices and other healthcare site settings, including, home care and home infusion providers and others.
Employees
467
Date Price Change Volume
26-09-15 US$12.15 -0.82% 35,575
26-09-14 US$12.25 +0.82% 108,275
26-09-11 US$12.15 +0.25% 137,047
26-09-10 US$12.12 -0.66% 146,413
26-09-09 US$12.20 +2.61% 175,398
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
12.25USD
Average target price
16.83USD
Spread / Average Target
+37.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INFU Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!